Gastroenterology
Gastroenterology Clinical Research
In the U.S., millions of patients are affected by gastrointestinal disorders, ranging from chronic conditions like IBS and IBD to liver and metabolic diseases. CenExel partners with sponsors to advance innovative GI therapies—delivering high-quality data, patient-focused care, and efficient trial execution across diverse populations.
Studies Conducted
Across gastrointestinal indications
0
+
Trial Participants
Enrolled in GI clinical studies
0
+
Active Sites
Specialized GI research locations
0
Overview
Leading Gastroenterology Clinical Research
Complex gastrointestinal trials require specialized scientific and operational expertise. CenExel’s GI research teams include experienced investigators, coordinators, and patient recruitment specialists—ensuring efficient study execution from first-patient-in to last-patient-out.
Our expertise spans inflammatory bowel diseases, liver disorders, and functional GI conditions. We integrate biomarker-driven strategies, advanced diagnostics, and patient-centric approaches to deliver high-quality outcomes across all trial phases.
Conditions Covered
Gastrointestinal Conditions We Research
Our GI research sites support a broad range of digestive and liver conditions—from common disorders to complex and rare indications.
Irritable Bowel Syndrome (IBS)
Crohn’s Disease
Ulcerative Colitis
Gastroesophageal Reflux Disease (GERD)
Nonalcoholic Steatohepatitis (NASH)
Fatty Liver Disease
Hepatitis B & C
Celiac Disease
Functional Dyspepsia
Constipation & Motility Disorders
Our Approach
Why Sponsors Choose CenExel for Gastroenterology
Our GI expertise goes beyond patient enrollment—we provide scientific insight, operational excellence, and reliable data for regulatory success.
01
GI Specialty Investigators
Experienced investigators with deep expertise in digestive and liver diseases ensure accurate diagnosis, protocol adherence, and high-quality data collection.
02
Biomarker & Endpoint Strategy
We integrate advanced biomarkers, imaging, and endoscopic endpoints to support early decision-making and trial success.
03
Diverse Patient Access
Access to diverse patient populations across multiple regions ensures representative data and improved enrollment performance.
04
Efficient Enrollment
Our in-house recruitment strategies consistently meet and exceed enrollment goals through targeted outreach and patient engagement.
Phase Coverage
Supported Trial Phases
CenExel supports early and late-phase gastroenterology clinical trials—from first-in-human studies to Phase IV post-marketing research.
Active across all phases
Phase I
Phase II
Phase III
Phase IV
Our early phase capabilities include pharmacodynamic biomarker strategies, first-in-human studies, and proof-of-concept trial design — guided by Chief Scientific Officer Dr. Larry Ereshefsky, an internationally recognized KOL in CNS research with over 30 years of early phase expertise.
Gastroenterology Task Force
CenExel’s Gastroenterology Task Force brings together experts across GI and hepatology to support complex clinical trials. From inflammatory bowel diseases to liver conditions and motility disorders, our teams ensure precision in study execution, patient safety, and high-quality data across all phases.
Active Sites
15 Sites
CenExel Gaithersburg
CenExel Garden Grove
CenExel Atlanta
CenExel Marlton
CenExel Hollywood
Related Therapeutic Areas
Also in Gastroenterology & Related Areas
Therapeutic Area
Hepatology
Liver diseases including NASH, hepatitis, and cirrhosis.
Therapeutic Area
Metabolic Disorders
Obesity, diabetes, and metabolic syndromes linked to GI health.
Therapeutic Area
Inflammatory Diseases
Chronic inflammatory conditions impacting digestive health.